✦ LIBER ✦

Modulation of multidrug resistance with antisense oligodeoxynucleotide to mdr1 mRNA

✍ Scribed by Juan E. Sola; Paul M. Colombani

Book ID: 112745260
Publisher: Springer
Year: 1996
Tongue: English
Weight: 503 KB
Volume: 3
Category: Article
ISSN: 1068-9265
DOI: 10.1007/bf02409056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of multidrug-resistant murine

Treatment of multidrug-resistant murine leukemia with antisense mdr1 oligodeoxynucleotides

✍ S Hiratake; E Azuma; Y Nishiguchi; M Nagai; M Ido; Y Komada; M Sakurai 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 662 KB

Modulation of expression of multidrug re

Modulation of expression of multidrug resistance gene (mdr-1) by adriamycin

✍ Shoko Kato; Junji Nishimura; Yuji Yufu; Hiroshi Ideguchi; Tsukuru Umemura; Hajim 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 441 KB

Sensitization of multidrug-resistant hum

Sensitization of multidrug-resistant human leukemia cells with MDR1-targeted antisense and inhibition of drug-mediated MDR1 induction

✍ Li, X; Smyth, A P; Barrett, D J; Ivy, S P; von Hofe, E 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 497 KB

Modulation of human multidrug-resistance

Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids

✍ Pornngarm Limtrakul; Songyot Anuchapreeda; Duang Buddhasukh 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 552 KB

Inhibition Growth of Multidrug Resistant

Inhibition Growth of Multidrug Resistant KBV200Cells by MDR1 Antisense RNA

✍ Yong Li; Yuzhi Wang 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Modulation of multidrug resistance by ve

Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line

✍ Licia Rivoltini; Mario P. Colombo; Rosanna Supino; Dario Ballinari; Takashi Tsur 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 674 KB

Two sublines were derived from the colon adenocarcinoma line LoVo, the first one was sensitive (LoVolH) and the second one was made resistant to doxorubicin (LoVolDx). When tested for susceptibility to lysis by different types of immune effectors, LoVo/Dx appeared more sensitive than LoVo/H to the k